Apple Inc. vs. REGEN BIOPHARMA INC
Apple Inc. and REGEN BIOPHARMA INC are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AAPL | RGBP | |
|---|---|---|
| Market Cap | $4.79 trillion | — |
| Revenue (TTM) | $466.82 billion | — |
| Net Income (TTM) | $128.93 billion | — |
AAPL and RGBP split the size & scale factors evenly.
Valuation
| AAPL | RGBP | |
|---|---|---|
| P/E Ratio | 36.74 | — |
| Price / Book | 44.55 | — |
| Price / Sales | 10.26 | — |
AAPL and RGBP split the valuation factors evenly.
Profitability
| AAPL | RGBP | |
|---|---|---|
| Net Margin | 27.62% | — |
| Return on Equity | 119.91% | — |
AAPL and RGBP split the profitability factors evenly.
Dividend
| AAPL | RGBP | |
|---|---|---|
| Dividend Yield | 0.34% | — |
| Payout Ratio | 12.40 | — |
AAPL and RGBP split the dividend factors evenly.
Risk & Sentiment
| AAPL | RGBP | |
|---|---|---|
| Short Interest | 0.31% | — |
AAPL and RGBP split the risk & sentiment factors evenly.
Dig deeper: AAPL overview, AAPL financials, RGBP overview, RGBP financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.